Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome (WAS)

This study has been completed.
Sponsor:
Collaborator:
Texas Children's Hospital
Information provided by (Responsible Party):
Soma Jyonouchi, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT00774358
First received: October 16, 2008
Last updated: September 2, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)